Search Results for: cell therapy
R&D Dermatology
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
ASGCT 2024 ASGCT Clinical Trials
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
ASGCT 2024 ASGCT Clinical Trials
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
ASGCT 2024 AI DevelopmentsCRISPRASGCT Day 1
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
ASGCT 2024 ASGCT Previews
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
ASGCT 2024 ASGCT Previews
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
ASGCT 2024 ASCGT Previews
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Ranking & Reports Q1 Financial Report
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Region Cell and Gene TherapyMoU
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Trials & Approvals Bladder CancerFDA Approval
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
R&D Hong KongCOVID-19
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Conference Biomedical ForumTechnological InnovationDigital Era
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
AACR 2024 New DrugsPart 2AACR 2024
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
AACR 2024 New DrugsPart 1AACR 2024
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Deals AcquisitionsVertex Pharmaceuticals
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
1 2 3 … 83
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top